Respiratory Syncytial Virus Infection Prevention
3 clinical trials · Condition
◉ Watch Respiratory Syncytial Virus Infection Prevention
| Record | Firm | Date |
|---|---|---|
| A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection (NCT05070546) | Janssen Vaccines & Prevention B.V. | 2021-09-29 |
Track Respiratory Syncytial Virus Infection Prevention automatically
Every clearance here is in the API, with alerts when new ones post.